Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Recent studies using magnetic resonance spectroscopy have shown that decreased insulin-stimulated muscle glycogen synthesis due to a defect in insulin-stimulated glucose transport activity is a major factor in the pathogenesis of type 2 diabetes. The molecular mechanism underlying defective insulin-stimulated glucose transport activity can be attributed to increases in intramyocellular lipid metabolites such as fatty acyl CoAs and diacylglycerol, which in turn activate a serine/threonine kinase cascade, thus leading to defects in insulin signaling through Ser/Thr phosphorylation of insulin receptor substrate (IRS)-1. A similar mechanism is also observed in hepatic insulin resistance associated with nonalcoholic fatty liver, which is a common feature of type 2 diabetes, where increases in hepatocellular diacylglycerol content activate protein kinase C-ε, leading to reduced insulin-stimulated tyrosine phosphorylation of IRS-2. More recently, magnetic resonance spectroscopy studies in healthy lean elderly subjects and healthy lean insulin-resistant offspring of parents with type 2 diabetes have demonstrated that reduced mitochondrial function may predispose these individuals to intramyocellular lipid accumulation and insulin resistance. Further analysis has found that the reduction in mitochondrial function in the insulin-resistant offspring can be mostly attributed to reductions in mitochondrial density. By elucidating the cellular and molecular mechanisms responsible for insulin resistance, these studies provide potential new targets for the treatment and prevention of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DAGs have been reported to reduce insulin sensitivity in skeletal muscle (25).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [25]
In the citing paper
“These traits are most often observed in association with aging, severe obesity and type 2 diabetes but were also evident in young insulin-resistant offspring of parents with diabetes [60,62].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [60]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The World Health Organization estimates that by the year 2030, 366 million people will be afflicted with diabetes (1).”
BackgroundMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“Downstream molecules such as phosphatidylinositol-dependent kinase (PDK) and protein kinase B (PKB [AKT]) have a pleckstrin homology domain that enables these molecules to migrate toward the plasma membrane (28).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Using a similar approach, we used (31)P MRS to examine mitochondrial function in young lean insulin-resistant offspring of parents with type 2 diabetes (20).”
BackgroundMethodSelf-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Using (13)C/(31)P MRS, we directly assessed mitochondrial oxidative and phosphorylation activity in the healthy lean elderly volunteers with severe muscle insulin resistance and found that they have an 40% reduction in rates of oxidative phosphorylation activity associated with increased intramyocellular and intrahepa…”
MethodSelf-citation
Cited by
Items 401–500 of 872
Zhao, L., Liu, Q., Jia, Y., Lin, H., Yu, Y., Chen, X., Liu, Z., Li, W., Fang, T., Jiang, W., et al. (2023) · Toxics · doi:10.3390/toxics11090741 · Cited by 32
Aspartame: Should Individuals with Type II Diabetes be Taking it?
Choudhary, A. K. (2017) · Current Diabetes Reviews · doi:10.2174/1573399813666170601093336 · Cited by 36
Obanda, D. N., & Cefalu, W. T. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.014 · Cited by 33
“Recent work from our laboratory has characterized the inhibitory effects of palmitic acid on insulin sensitivity and overexpression of PTP1B, a phosphatase that impairs insulin signaling by dephosphorylating the insulin receptor and post-insulin receptor substrates such as Insulin receptor substrate 1 (IRS-1) [7].”
BackgroundInfluentialMitoflash altered by metabolic stress in insulin-resistant skeletal muscle
Ding, Y., Fang, H., Shang, W. H., Xiao, Y., Sun, T., Hou, N., Pan, L., Sun, X., Ma, Q., Zhou, J., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1278-y · Cited by 32
Raeisi‐Dehkordi, H., Amiri, M., Zimorovat, A., Moghtaderi, F., Zarei, S., Forbes, S. C., & Salehi‐Abargouei, A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3399 · Cited by 32
“Modifying intramuscular fat deposition following unsaturated fatty acids intake is another possible mechanism for alleviating insulin resistance since SFAs, unlike unsaturated fatty acids, tend to aggregate fat deposition and cause insulin resistance.(62) The present study has several strengths and limitations.”
BackgroundChung, Y.-L., Hou, Y., Wang, I., Lu, K., & Yen, T. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1818 · Cited by 31
Reduced leukocyte mitochondrial copy number in metabolic syndrome and metabolically healthy obesity
Agius, R., Pace, N. P., & Fava, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886957 · Cited by 32
Lecube, A., Sampol, G., Muñoz, X., Lloberes, P., Hernández, C., & Simó, R. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1131 · Cited by 35
“It has been shown that insulin-resistant populations show reduced mitochondrial fitness in skeletal muscle [26,27].”
BackgroundLebovitz, H. E., Ludvik, B. H., Yaniv, I., Haddad, W., Schwartz, T. P., & Aviv, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12132 · Cited by 31
Eid, H. M., Vallerand, D., Asim, M., Durst, T., Haddad, P. S., & Martineau, L. C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.026 · Cited by 37
“At the cellular level, the development of insulin resistance is caused in part by abnormal accumulation and metabolism of lipids, as well as by mitochondrial dysfunction [2,3].”
BackgroundZmynd17 controls muscle mitochondrial quality and whole‐body metabolism
Fujita, R., Yoshioka, K., Seko, D., Suematsu, T., Mitsuhashi, S., Senoo, N., Miura, S., Nishino, I., & Ono, Y. (2018) · The FASEB Journal · doi:10.1096/fj.201701264r · Cited by 30
“Mitochondrial dysfunction in muscle is associated with development of systemic glucose intolerance and insulin resistance (3, 15, 16, 38, 39).”
BackgroundLøvås, K., Røst, T. H., Skorve, J., Ulvik, R. J., Gudbrandsen, O. A., Bohov, P., Wensaas, A. J., Rustan, A. C., Berge, R. K., & Husebye, E. S. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00958.x · Cited by 31
Clemente‐Suárez, V. J., Rubio-Zarapuz, A., Belinchón-deMiguel, P., Beltrán-Velasco, A. I., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2024) · Cells · doi:10.3390/cells13231940 · Cited by 31
Assessment of plasma acylcarnitines before and after weight loss in obese subjects
Schooneman, M. G., Napolitano, A., Houten, S. M., Ambler, G. K., Murgatroyd, P. R., Miller, S. R., Hollak, C. E. M., Tan, C. Y., Virtue, S., Vidal‐Puig, A., et al. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.07.013 · Cited by 34
“mitochondrial content or capacity may result in elevated intracellular lipids (3, 5).”
BackgroundMethodLeber, A. J., Hontecillas, R., Tubau‐Juni, N., Zoccoli-Rodriguez, V., Goodpaster, B. H., & Bassaganya-Riera, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-67300-2 · Cited by 31
Wang, H., Chen, Z., Wang, M., Long, M., Ren, T., Chen, C., Dai, X., Yang, S., & Tan, S. (2022) · Foods · doi:10.3390/foods11121747 · Cited by 31
Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
Gordon, J. W., Dolinsky, V. W., Mughal, W., Gordon, G. R. J., & McGavock, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0012 · Cited by 30
Valkovič, L., Ukropcová, B., Chmelík, M., Baláž, M., Bogner, W., Schmid, A. I., Frollo, I., Zemková, E., Klimeś, I., Ukropec, J., et al. (2013) · NMR in Biomedicine · doi:10.1002/nbm.3008 · Cited by 31
“Changes related to these mitochondrial pathologies could indicate profound defects in lipid metabolism, resulting in the progression of obesity and metabolic disease even in a young, sedentary population (7,8).”
BackgroundKruglov, A. G., Andersson, M. A., Mikkola, R., Roivainen, M., Kredics, L., Saris, N.-E. L., & Salkinoja-Salonen, M. S. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800317z · Cited by 33
Chen, S., Wu, F., Yang, C., Zhao, C., Cheng, N., Cao, W., & Zhao, H. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c03639 · Cited by 29
Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity
Rautenberg, E. K., Hamzaoui, Y., & Coletta, D. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968268 · Cited by 33
Diet-Induced Obesity Prevents Interstitial Dispersion of Insulin in Skeletal Muscle
Kolka, C. M., Harrison, L. N., Lottati, M., Chiu, J. D., Kirkman, E. L., & Bergman, R. N. (2009) · Diabetes · doi:10.2337/db09-0839 · Cited by 29
“There are a number of loci where insulin action can be altered, including the direct effect of inflammatory cytokines to attenuate distribution of blood flow and glucose uptake (7), and direct effects of plasma free fatty acids (FFAs) to impede insulin signaling in the cell (4) and/or reduce capillary recruitment (8).”
BackgroundWu, S.-J., Tung, Y.-J., & Ng, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112962 · Cited by 29
Glycemic load and risk of Alzheimer's disease.
Luchsinger, J. A., Tang, M. ‐., & Mayeux, R. P. (2007) · PubMed · Cited by 34
Weismann, D., Erion, D. M., Ignatova-Todorava, I., Nagai, Y., Stark, R., Hsiao, J. J., Flannery, C. A., Birkenfeld, A. L., May, T., Kahn, M., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1984-5 · Cited by 38
“In the pathogenesis of insulin resistance, accumulation of diacylglycerol in muscle and liver leads to activation of novel protein kinase Cs (θ and ε, respectively) that inhibit insulin signalling and impair activation of AKT2 [1, 4, 5].”
BackgroundSelf-citationLenaers, E., Feyter, H. M. D., Hoeks, J., Schrauwen, P., Schaart, G., Nabben, M., Nicolay, K., Prompers, J. J., & Hesselink, M. K. C. (2009) · Obesity · doi:10.1038/oby.2009.372 · Cited by 28
Sparks, L. M., Bosma, M., Brouwers, B., van de Weijer, T., Bilet, L., Schaart, G., Moonen-Kornips, E., Eichmann, T. O., Lass, A., Hesselink, M. K. C., et al. (2014) · Diabetes · doi:10.2337/db13-1123 · Cited by 27
“It has been proposed that an increased lipid supply, altered lipid partitioning and a reduced capacity for skeletal muscle fat oxidation could contribute to intramyocellular lipid (IMCL) accumulation, lipotoxicity and insulin resistance (2-4).”
BackgroundMulya, A., Haus, J. M., Solomon, T. P. J., Kelly, K. R., Malin, S. K., Rocco, M., Barkoukis, H., & Kirwan, J. P. (2017) · Obesity · doi:10.1002/oby.21799 · Cited by 28
“Suppression of skeletal muscle PGC-1a is associated with increased energy intake (9,10) and the development of obesity, diabetes, and metabolic diseases (11).”
BackgroundObesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 30
Dedov, I. I., Va, T., Gusev, N. B., Shirinsky, V. P., Vorotnikov, A. V., Kochegura, T. N., Mayorov, A. Y., & Shestakova, M. V. (2018) · Diabetes Mellitus · doi:10.14341/dm9730 · Cited by 29
Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes
Pujia, A., Mazza, E., Ferro, Y., Gazzaruso, C., Coppola, A., Doldo, P., Grembiale, R. D., Pujia, R., Romeo, S., & Montalcini, T. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00806 · Cited by 30
Shi, L., Sun, R., Wang, D., Mei-zhen, G., Su, X.-P., Yi, F., & Peng, Z. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00270 · Cited by 35
“Mitochondrial dysfunction increases predisposition to intracellular lipid accumulation (Morino et al., 2006; Schrauwen et al., 2010; Su et al., 2010) and non-alcoholic steatohepatitis (NASH) (Cortez-Pinto et al., 1999; Sanyal et al., 2001; Pérez-Carreras et al., 2003; Rector et al., 2010).”
BackgroundFrelut, M., Nicolas, J., Guilland, J.-C., & de Courcy, G. P. (2010) · International Journal of Pediatric Obesity · doi:10.3109/17477166.2010.486835 · Cited by 28
Park, S., Seo, E.-H., Bae, D.-H., Kim, S. S., Kim, J., Lin, W., Kim, K., Park, J. B., Kim, S., Yin, J., et al. (2019) · PubMed Central · doi:10.14348/molcells.2019.0160 · Cited by 33
Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes
Elekofehinti, O. O., Omotuyi, O. I., Kamdem, J. P., Ejelonu, O. C., Olher, V. G. A., Adanlawo, I. G., & da Rocha, J. B. T. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0325-4 · Cited by 27
“Downregulation of Glut4 expression in adipose tissue is an almost universal feature of insulin-resistant states, including obesity, type 2 diabetes, and metabolic syndrome [82].”
BackgroundSimilarities and interactions between the ageing process and high chronic intake of added sugars
Gatineau, E., Polakof, S., Dardevet, D. P., & Mosoni, L. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000051 · Cited by 29
“described in a review by Morino et al.((103)).”
Schwarz, S., Mrosewski, I., Silawal, S., & Schulze-Tanzil, G. G. (2017) · Inflammation Research · doi:10.1007/s00011-017-1121-8 · Cited by 28
Nobuhara, M., Saotome, M., Watanabe, T., Urushida, T., Katoh, H., Satoh, H., Funaki, M., & Hayashi, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.004 · Cited by 30
“by perhexiline may cause further accumulation of TAG and other lipid metabolites, which in turn worsen lipid-induced insulinresistance [41].”
BackgroundFatty acid-induced atherogenic changes in extracellular matrix proteoglycans
Rodríguez-Lee, M., Bondjers, G., & Camejo, G. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ef534f · Cited by 29
Franceschini, L. A., Realdon, S., Marcolongo, M., Mirandola, S., Bortoletto, G., & Alberti, A. (2011) · Hepatology · doi:10.1002/hep.24394 · Cited by 27
Chung, E., Campise, S. N., Joiner, H. E., Tomison, M. D., Kaur, G., Dufour, J. M., Cole, L., Ramalingam, L., Moustaid-Moussa, N., & Shen, C.-L. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.021 · Cited by 26
de Queiroz, K. B., Sampaio, K. H., Rossoni, J. V., Leal, D. A., Pinto, A. B. G., Becker, L. K., Evangelista, E. A., & Guerra‐Sá, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172103 · Cited by 27
Pascottini, O. B., Carvalho, M. R., Schyndel, S. J. V., Ticiani, E., Sprícigo, J. F. W., Mamedova, L. K., Ribeiro, E. S., & LeBlanc, S. J. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16558 · Cited by 26
Effects of sodium salicylate on glucose kinetics and insulin signaling in postpartum dairy cows
Montgomery, S. R., Mamedova, L. K., Zachut, M., Kra, G., Häussler, S., Vaughn, M. A., Gonzalez, J. M., & Bradford, B. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-15312 · Cited by 25
Grapentine, S., & Bakovic, M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.33.20180104 · Cited by 29
Baylan, F. A., & Yarar, E. (2021) · Sleep And Breathing · doi:10.1007/s11325-020-02273-0 · Cited by 25
“mitochondrial biogenesis, decreased mitochondrial mass, altered mitochondrial morphology, and structural damage, have been described [12, 13].”
BackgroundHigh-Density Lipoprotein Lipidomics in Chronic Kidney Disease
Lidgard, B., Hoofnagle, A. N., Zelnick, L. R., de Boer, I. H., Fretts, A. M., Kestenbaum, B. R., Lemaître, R. N., Robinson‐Cohen, C., & Bansal, N. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvac216 · Cited by 25
IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling
Valverde, Á. M., & González‐Rodríguez, Á. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.557386 · Cited by 34
“, 2006) whereas serine phosphorylation negatively modulates IRS1-mediated insulin signalling (Morino et al., 2006).”
Backgroundvan Vonderen, M. G. A., Blümer, R. M. E., Hassink, E. A. M., Sutinen, J., Ackermans, M. T., van Agtmael, M. A., Yki‐Järvinen, H., Danner, S. A., Serlie, M. J. M., Sauerwein, H. P., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c190f4 · Cited by 25
“How mitochondrial dysfunction interferes with peripheral insulin sensitivity has not been fully clarified yet, but accumulation of intracellular FFA metabolites due to reduced oxidative capacity may be one mechanism.(14) The observed transient changes in lipolysis during hyperinsulinemia (ie, insulin sensitivity of ad…”
BackgroundSánchez-Muñoz, M. A., Valdez-Solana, M. A., Campos-Almazán, M. I., Flores-Herrera, Ó., Esparza-Perusquía, M., Olvera-Sánchez, S., García‐Arenas, G., Avitia-Domínguez, C. I., Téllez‐Valencia, A., & Sierra‐Campos, E. (2018) · Biochemistry Research International · doi:10.1155/2018/5681081 · Cited by 29
“Mitochondrial dysfunction has recently been identified as a common metabolic defect associated with diabetes, obesity, and its metabolic complications [10, 11].”
Morris, E. M., Whaley‐Connell, A. T., Thyfault, J. P., Britton, S. L., Koch, L. G., Wei, Y., Ibdah, J. A., & Sowers, J. R. (2009) · American Journal of Nephrology · doi:10.1159/000204362 · Cited by 31
Association of the CPT1B Gene with Skeletal Muscle Fat Infiltration in Afro‐Caribbean Men
Miljkovic, I., Yerges, L. M., Hu, L., Gordon, C. L., Goodpaster, B. H., Kuller, L. H., Nestlerode, C. S., Bunker, C. H., Patrick, A. L., Wheeler, V. W., et al. (2009) · Obesity · doi:10.1038/oby.2008.677 · Cited by 27
“Our results suggest that inherited differences in the function of CPT1B, a key enzyme in the regulation of the mitochondrial β-oxidation, may impair long-chain fatty acid metabolism and predispose to increased skeletal muscle fat infiltration (5).”
BackgroundLessons learned from studying families genetically predisposed to type 2 diabetes mellitus
Cusi, K. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0033-6 · Cited by 27
Tip60-mediated Rheb acetylation links palmitic acid with mTORC1 activation and insulin resistance
Zhao, Z., Chen, Q., Xiang, X., Dai, W., Fang, W., Cui, K., Li, B., Liu, Q., Liu, Y., Shen, Y.-N., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202309090 · Cited by 25
Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases
Iqbal, J., Jahangir, Z., & Qarni, A. A. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_4 · Cited by 26
Insulin resistance and lipid disorders
Miccoli, R., Keyzer, D. D., Penno, D. G., & Prato, D. S. D. (2008) · Future Lipidology · doi:10.2217/17460875.3.6.651 · Cited by 32
Skeletal muscle lipid flux: running water carries no poison
Funai, K., & Semenkovich, C. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00152.2011 · Cited by 27
“131 Therefore, it is not likely that elevated mitochondrial mass alone (73, 79) in the absence of 132”
BackgroundDiabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 27
Murata, K., Morino, K., Ida, S., Ohashi, N., Lemecha, M., Park, S., Ishikado, A., Kume, S., Choi, C. S., Sekine, O., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.081 · Cited by 24
“Insulin resistance in skeletal muscle is considered to be an early defect in the development of type 2 diabetes [2].”
BackgroundSelf-citationCyanidin-3-glucoside enhances mitochondrial function and biogenesis in a human hepatocyte cell line
Mogalli, R., Matsukawa, T., Shimomura, O., Isoda, H., & Ohkohchi, N. (2018) · Cytotechnology · doi:10.1007/s10616-018-0242-4 · Cited by 24
Li, M., Mínguez‐Alarcón, L., Bellavia, A., Williams, P. L., James-Todd, T. M., Hauser, R. B., Chavarro, J. E., & Chiu, Y. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108729 · Cited by 24
Overview of the physiological changes and optimal diet in the golden age generation over 50
Gille, D. (2010) · European Review of Aging and Physical Activity · doi:10.1007/s11556-010-0058-5 · Cited by 30
“These dysfunctions and shifts are accompanied by a decreased metabolic function of the whole metabolism (especially mitochondria) leading to reduced overall activity [33].”
BackgroundBosma, M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.007 · Cited by 23
Shin, J., Jeon, S.-H., Lee, S. J., & Choung, S. (2022) · Nutrients · doi:10.3390/nu14091747 · Cited by 23
Bains, V. K., Mahendra, J., Mahendra, L., Mittal, M., & Valli, G. (2022) · Journal of International Society of Preventive and Community Dentistry · doi:10.4103/jispcd.jispcd_92_22 · Cited by 26
“It can be comprehended that periodontal disease is a recognized amendable risk factor for T2D.”
BackgroundInfluentialJørgensen, W., Jelnes, P., Rud, K. A., Hansen, L. L., Grunnet, N., & Quistorff, B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2012 · Cited by 23
“The involvement of mitochondria in the pathogenesis of insulin resistance and T2DM has been implicated by many studies for more than a decade (26, 37, 44, 51).”
BackgroundNisr, R. B., & Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.04.286 · Cited by 23
“It is highly conceivable that the oxidative capacity of muscle cells in obese subjects is insufficient to burn the elevated NEFA supply effectively [7,12] and thus causes accumulation of metabolites that blunt insulin responsiveness.”
BackgroundLaskowski, D., Båge, R., Humblot, P., Andersson, G., Sirard, M., & Sjunnesson, Y. C. B. (2017) · Theriogenology · doi:10.1016/j.theriogenology.2017.06.002 · Cited by 24
Lopez-Carmona, M. D., Plaza‐Seron, M. D. C., Vargas‐Candela, A., Tinahones, F. J., Gómez-Huelgas, R., & Bernal-López, M. R. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0253-x · Cited by 24
Hui, S. T. Y., Wang, F., Stappenbeck, F., French, S. W., Magyar, C. E., Parhami, F., & Lusis, A. J. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.296 · Cited by 23
Kwak, H., Woodlief, T., Green, T. D., Cox, J. H., Hickner, R. C., Neufer, P. D., & Cortright, R. N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071157 · Cited by 25
Wallenius, K., Kjellstedt, A., Thalén, P., Löfgren, L., & Oakes, N. D. (2013) · PPAR Research · doi:10.1155/2013/305347 · Cited by 22
“…August 2013 Academic Editor: Brian Finck Copyright © 2013 Kristina Wallenius et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodMild obesity reduces survival and adiponectin sensitivity in endotoxemic rats
Sakaï, S., Iizuka, N., Fujiwara, M., Miyoshi, M., Aoyama, M., Maeshige, N., Hamada, Y., Usami, Y., & Usami, M. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.06.002 · Cited by 23
“PGC-1α regulates mitochondrial biogenesis [40], and its expression in the liver is decreased in endotoxemia [41].”
Preserved Lower Limb Muscle Mass Prevents Insulin Resistance Development in Nondiabetic Older Adults
Seko, T., Akasaka, H., Koyama, M., Himuro, N., Saitoh, S., Miura, T., Mori, M., & Ohnishi, H. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.12.002 · Cited by 25
Kaneko, S., Iida, R., Suga, T., Fukui, T., Morito, M., & Yamane, A. (2011) · The Anatomical Record · doi:10.1002/ar.21472 · Cited by 21
“NRF1 is a transcription factor stimulating many nuclear-encoded mitochondrial genes such as mitochondrial transcription factor A (mtTFA), a key transcriptional factor for the mitochondrial genome (Morino et al., 2006).”
BackgroundMetabolic Dysfunction in Diabetic Offspring
Russell, R., Kraemer, R. R., & Nelson, A. G. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31826909d3 · Cited by 22
“can be examined at its earliest time points (27).”
BackgroundResultDong, S.-S., Guo, Y., Zhu, D.-L., Chen, X.-F., Wu, X.-M., Shen, H., Chen, X.-D., Tan, L.-J., Tian, Q., Deng, H.-W., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.44 · Cited by 22
Ferdowsi, P. V., Ahuja, K., Beckett, J. M., & Myers, S. (2023) · Molecules · doi:10.3390/molecules28062861 · Cited by 23
“IR manifests in peripheral tissues through various mechanisms [36,60,61].”
Zahmatkesh, A., Sohouli, M. H., Shojaie, S., & Rohani, P. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05369-3 · Cited by 26
“FFA and hepatic TG stimulate the reduction in insulin-induced glucose uptake and cause intracellular inflammation [38, 39].”
Mitochondrial DNA content and function, childhood obesity, and insulin resistance
Shoar, Z., Goldenthal, M. J., Luca, F. D., & Suarez, E. A. (2015) · Endocrine Research · doi:10.3109/07435800.2015.1068797 · Cited by 24
“metabolism and mitochondrial function can be involved in the pathogenesis of type 2 diabetes and insulin resistance (31,32).”
BackgroundComputational Modeling and Analysis of Insulin Induced Eukaryotic Translation Initiation
Lequieu, J. P., Chakrabarti, A., Nayak, S., & Varner, J. D. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002263 · Cited by 27
“Insulin, the primary hormone regulating the level of glucose in the bloodstream, modulates a variety of cellular and enzymatic processes in normal and diseased cells [133, 73, 21, 88, 101, 131, 26].”
BackgroundRašić-Milutinović, Z., Peruničić-Peković, G., Cavala, A., Gluvic, Z. M., Bokan, L., & Stankovic, S. D. (2008) · PubMed Central · Cited by 21
Sarkar, J., Dwivedi, G., Chen, Q., Sheu, I. E., Paich, M., Chelini, C. M., D'Alessandro, P. M., & Burns, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192472 · Cited by 23
Sen, I., Bozkurt, O., Aras, E., Heise, S., Brockmann, G. A., & Severcan, F. (2015) · Applied Spectroscopy · doi:10.1366/14-07443 · Cited by 21
Maassen, J. A., Hart, L. M. ‘., & Ouwens, D. M. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f0b774 · Cited by 22
MAP kinase phosphatase-1 - a new player at the nexus between sarcopenia and metabolic disease
Flach, R. J. R., & Bennett, A. M. (2010) · Aging · doi:10.18632/aging.100135 · Cited by 23
“For example, increases in cellular insults such as ROS and intramyocellular lipids, which increase during aging [57, 58], may trigger increased MKP-1expression, thus negatively regulating p38 MAPK activity, and therefore, PGC-1α stability.”
BackgroundBogazzi, F., Raggi, F., Russo, D., Bohlooly‐Y, M., Sardella, C., Urbani, C., Lombardi, M., Manetti, L., Lupi, I., Törnell, J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1220 · Cited by 20
Experimental Hyperlipidemia Dramatically Reduces Access of Insulin to Canine Skeletal Muscle
Chiu, J. D., Kolka, C. M., Richey, J. M., Harrison, L. N., Zuniga, E. A., Kirkman, E. L., & Bergman, R. N. (2009) · Obesity · doi:10.1038/oby.2009.165 · Cited by 20
“Intracellular lipids in muscle and liver can interfere with oxidative phosphorylation in the mitochondria, activating kinases that reduce insulin signaling and glucose transport (8).”
BackgroundQin, D., Zhu, J., Ji, C., Chunmei-Shi, Kou, C., Zhu, G.-Z., Zhang, C., Wang, Y., Ni, Y., & Guo, X. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9360-9 · Cited by 21
“A well-documented example of a PI3K downstream target is the protein Ser/Thr kinase, Akt, which is activated via membrane localization (Moldes et al. 2001) and Ser/Thr phosphorylation ( Morino et al. 2006; Ohgami et al. 2006).”
BackgroundPorzio, A. D., Barrella, V., Gatto, C., Cigliano, L., Spagnuolo, M. S., Crescenzo, R., Romano, I., Mauriello, G., Iossa, S., & Mazzoli, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105805 · Cited by 19
Sharma, T. S., Jacobson, D. L., Anderson, L. M., Gerschenson, M., Dyke, R. B. V., McFarland, E. J., & Miller, F. T. P. H. A. T. L. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0354 · Cited by 19
“development of insulin resistance is also established.(13) A clear link between ARV-associated mitochondrial dysfunction and insulin resistance, although demonstrated in adults, has yet to be identified in HIV-infected children.”
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
Kim, K., Choi, Y. K., Kim, M. J., Hwang, J. W., Min, K., Jung, S. Y., Kim, S.-K., Cho, Y.-W., & Cho, Y.-W. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0191 · Cited by 22
“Mitochondrial biogenesis might be associated with insulin resistance through GLUT4 translocation, the insulin-signaling pathway, and inflammation [30-32].”
BackgroundHe, B., Piao, D., Yu, C., Wang, Y., & Han, P. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0997-9 · Cited by 21
Pandey, J., Maurya, R., Raykhera, R., Srivastava, M. N., Yadav, P. P., & Tamrakar, A. K. (2014) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6555 · Cited by 19
Molecular Basis of Cardiomyopathies in Type 2 Diabetes
Giardinelli, S., Meliota, G., Mentino, D., D’Amato, G., & Faienza, M. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158280 · Cited by 18
“In individuals with T2DM, defects in the mitochondrial structure and function contribute to the development of insulin resistance in skeletal muscle, adipose tissue and pancreatic β -cells [37,38].”
BackgroundAlipourfard, I., Bakhtiyari, S., Gheysarzadeh, A., Renzo, L. D., LORENZO, A. D., Mikeladze, D., & Khamoushi, A. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200427102209 · Cited by 18
Morino, K., & Maegawa, H. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13359 · Cited by 20
Self-citationSong, K., Zhang, Y., Ga, Q., Bai, Z., & Ge, R. (2020) · Obesity Facts · doi:10.1159/000508112 · Cited by 20
Blackwood, S. J., Horwath, O., Moberg, M., Pontén, M., Apró, W., Ekblom, M., Larsen, F. J., & Katz, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac221 · Cited by 18
Karsenty, J., Landrier, J., Rousseau‐Ralliard, D., Masson, V. R., Margotat, A., Deprez, P., Lechêne, P., Grynberg, A., Lairon, D., Planells, R., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0488-0 · Cited by 18
Metadata
- Authors
- Morino, K., Petersen, K. F., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 55
- Issue
- Supplement_2
- Pages
- S9-S15
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2995546
- OpenAlex
- W2114416343
- Cited by
- 853
- References
- 91
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 29 · 2023: 35 · 2022: 26 · 2021: 28 · 2020: 48 · 2019: 38 · 2018: 42 · 2017: 39 · 2016: 60 · 2015: 34 · 2014: 53 · 2013: 54 · 2012: 63
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- U.S. Public Health Service (P30 DK45735, R01 DK-40936, R01 AG23686)
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, U24DK59635, P01 DK-063229, R01DK040936, U24DK059635, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, mitochondrial dysfunction, insulin-stimulated glucose transport, muscle glycogen synthesis, intramyocellular lipid, fatty acyl-CoA, diacylglycerol, protein kinase C epsilon, IRS-1, insulin receptor substrate 2, hepatic insulin resistance, non-alcoholic fatty liver disease, mitochondrial density, magnetic resonance spectroscopy
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Liver, Mitochondria, Muscle, Muscles, Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.